A Multicentric Open Randomised, Cross-over Phase III Trial Assessing the Treatment Compliance With GRAZAX in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Timothy grass pollen allergen extract (Grastek) (Primary)
- Indications Allergic rhinoconjunctivitis; Grass pollen hypersensitivity
- Focus Registrational; Therapeutic Use
- Sponsors ALK-Abello
- 21 Dec 2012 New trial record